摘要
目的:观察和分析奥曲肽治疗肝硬化上消化道出血的临床效果。方法:选取2013年8月-2014年1月笔者所在医院收治的肝硬化上消化道出血患者56例,随机分为对照组和观察组,两组均给予恩替卡韦进行肝硬化的基础治疗,同时对照组采用垂体后叶素治疗,观察组采用奥曲肽进行治疗。连续治疗8周,观察两组患者的临床治疗效果。结果:观察组总有效率为92.86%,对照组总有效率为71.43%,观察组的治疗效果优于对照组,差异有统计学意义(P<0.05)。观察组临床症状、体征恢复时间优于对照组(P<0.05)。结论:在基础治疗基础上加用奥曲肽治疗肝硬化上消化道出血疗效好。
Objective： To observe and analyze the clinical effect of Octreotide in the treatment of liver cirrhosis with upper digestive tract bleeding. Method： 60 cases of liver cirrhosis with upper digestive tract bleeding from August 2013 to January 2014 were selected, and they were randomly divided into the control group and the observation group.Both groups received cirrhosis oriented basic treatment with Entecavir.Meanwhile, the control group was performed Pituitrin treatment for the upper digestive tract bleeding, while the observation group took Octreotide for the bleed.The clinical outcomes of the two groups were observed after continuous treatment for 8 weeks.Result： The total efficacy of patients in the observation group was 92.86%, while the control group was 71.43%, the treatment efficacy of the observation group was better than that of the control group, the difference was statistical significance（P〈0.05）.The clinical symptom and signs of recovery time in the observation group were shorter than the control group（P〈0.05）.Couelusion： On the basis of basic treatment, the Octreotide has good effect in treatment of liver cirrhosis with upper gastrointestinal.
出处
《中外医学研究》
2015年第9期7-9,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
奥曲肽
肝硬化
上消化道出血
Octreotide
Cirrhosis
Upper digestive tract bleeding
